Avastin helps women who are suffering from ovarian cancerOctober 12th, 2010 - 8:09 pm ICT by Aishwarya Bhatt
New York, Oct 12 (THAINDIAN NEWS) The drug Avastin has been found to help women with ovarian cancer live longer without increasing the severity of their condition.
However the drug’s positive effect lasts for a maximum of 12 months and the effect diminishes afterwards.
The finding was as a result of a research that was announced on Monday. According to the report of the research, the drug extends the excepted lifespan of the patient by 1.5 months without their disease getting worse.
The search for a drug for ovarian cancer drug has not yielded any major breakthrough but scientists believe the drug can provide a leap forward in managing ovarian cancer.
However Avastin is not the only option that is being considered for the management of the disease. Other drugs including Amgen’s AMG 386 have all shown considerable signs in tests.
The drug, which is manufactured by Roche, is currently used in the management of breast, bowel, lung and other forms of cancer. In 2009, the drug grossed some $6 billion in sales throughout the world.
Roche’s bid to expand the drug’s benefits to other forms of cancer hit a snag this year as the drug failed trial runs for prostate and gastric cancer. The drug’s effectiveness in breast cancer management has also been doubted.
- Drug discovery combats ovarian cancer - Jun 05, 2011
- Cancer drug could combat ovarian tumours - Oct 12, 2010
- Wonder drug could kill all types of cancer - Jun 27, 2011
- Study shows that a new experimental cancer drug delays breast tumor growth - Jun 05, 2012
- How does cancer spread? - Dec 12, 2010
- Eating five fruits, veggies daily won't keep cancer at bay - Dec 01, 2010
- Super vaccine could knock out 70 percent of cancers - Dec 13, 2011
- Molecule that can starve cancer cells and tumors they produce identified - Sep 19, 2010
- Faulty gene spikes prostate cancer risk in men - Apr 22, 2012
- 'Wonder drug' a true cancer-buster - Sep 16, 2009
- Aspirin cuts prostate cancer risk - Oct 27, 2010
- Long-sought-after anti-cancer agent synthesized - Feb 01, 2011
- New genetic links to ovarian cancer risk discovered - Sep 20, 2010
- Fake eye drug affects over 60 Chinese - Sep 24, 2010
- Exercise can cut risk of cancer returning - Aug 08, 2011
Tags: 12 months, 5 months, amg, amgen, avastin, breakthrough, breast cancer, breast cancer management, cancer drug, drugs, gastric cancer, leap, lifespan, ovarian cancer, roche, scientists, severity, signs, snag